You have 9 free searches left this month | for more free features.

malignant ascites

Showing 1 - 25 of 6,129

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Malignant Ascites Trial in Taichung (Nivolumab, Pembrolizumab)

Enrolling by invitation
  • Malignant Ascites
  • Taichung, Please Select, Taiwan
    China Medical University Hospital
Feb 16, 2023

Gastric Cancer, Peritoneal Metastases, Ascites, Malignant Trial in Hangzhou (Sintilimab in Combination With S-1/oxaliplatin With

Recruiting
  • Gastric Cancer
  • +2 more
  • Sintilimab in Combination With S-1/oxaliplatin With nab-paclitaxel intraperitoneal infusion
  • Blood samples, tumor biopsy specimens, ascites, and feces samples will be collected
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Sep 18, 2023

Malignant Pleural Effusion, Malignant Ascites Trial in Pittsburgh (Tocilizumab)

Not yet recruiting
  • Malignant Pleural Effusion
  • Malignant Ascites
  • Pittsburgh, Pennsylvania
    Allegheny Health Network Cancer Institute
Aug 30, 2023

Malignant Ascites Trial (Serplulimab, Molgramostim, Hypofractionated radiotherapy/Sterotactic body radiotherapy)

Not yet recruiting
  • Malignant Ascites
  • (no location specified)
Aug 11, 2022

Refractory Malignant Ascites Trial in Shanghai (Oncorine (H101))

Recruiting
  • Refractory Malignant Ascites
  • Oncorine (H101)
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Mar 15, 2022

Refractory Malignant Ascites Trial in Shanghai (H101, Tislelizumab)

Recruiting
  • Refractory Malignant Ascites
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Apr 2, 2022

Gastric Cancer, Pancreatic Cancer Trial in Fukuoka-shi (Phase I part, Phase II part)

Recruiting
  • Gastric Cancer
  • Pancreatic Cancer
  • Phase I part
  • Phase II part
  • Fukuoka-shi, Fukuoka, Fukuoka, Japan
    Kyushu University Hospital
Jun 24, 2022

Management of Malignant Ascites by Interventional Radiology

Withdrawn
  • Refractory Malignant Ascites
  • Paracentesis
  • +2 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Jan 11, 2022

QOL and Sarcopenia in Patients With Ascites

Not yet recruiting
  • Ascites Hepatic
  • Ascites, Malignant
  • Quality of Life surveys
  • Philadelphia, Pennsylvania
    University of Pennsylvania Perelman School of Medicine
Feb 10, 2023

Peritoneal Carcinomatosis, Peritoneal Metastases, Colorectal Cancer Trial in New Brunswick, Providence (anti-CEA CAR-T cells)

Withdrawn
  • Peritoneal Carcinomatosis
  • +6 more
  • anti-CEA CAR-T cells
  • New Brunswick, New Jersey
  • +1 more
Mar 25, 2022

Malignant and Non-malignant Pleural Effusions and asCitic Fluid

Recruiting
  • Pleural Effusion
  • Ascites
    • Portsmouth, United Kingdom
      Portsmouth Hospitals NHS Trust
    Sep 30, 2022

    Malignant Peritoneal Effusion, Malignant Ascites, Serous Cavity Metastatises Trial in Chengdu (Dual-targeting VEGFR1 and PD-L1

    Not yet recruiting
    • Malignant Peritoneal Effusion
    • +2 more
    • Dual-targeting VEGFR1 and PD-L1 CAR-T cells
    • Chengdu, Sichuan, China
      West China Hospital, Sichuan University
    Jul 26, 2022

    Malignant Fluid Cells as a Biomarker for Rapid Therapy Guidance

    Recruiting
    • Pleural Effusion, Malignant
    • +2 more
      • Oakland, California
        xCures
      Aug 15, 2022

      Malignant Ascites, Ovarian Cancer, Hemodynamic Instability Trial in Berlin (Paracentesis)

      Completed
      • Malignant Ascites
      • +2 more
      • Paracentesis
      • Berlin, Germany
        Charite-University Medicine of Berlin, Department of Gynecology-
      Dec 6, 2020

      Pleural Effusion, Malignant Trial (IFN-? and CIK cells, Tcm cells or CAR T cells)

      Not yet recruiting
      • Pleural Effusion, Malignant
      • IFN-γ and CIK cells, Tcm cells or CAR T cells
      • (no location specified)
      Mar 16, 2022

      Refractory Ovarian Cancer With Recurrent Symptomatic Malignant Ascites Trial in United States (BAX69 Single-Route Arm, BAX69

      Terminated
      • Refractory Ovarian Cancer With Recurrent Symptomatic Malignant Ascites
      • BAX69 Single-Route Arm
      • BAX69 Double-Route Arm
      • Miami, Florida
      • +5 more
      Dec 22, 2020

      Malignant Ascites Alfapump® Study

      Withdrawn
      • Malignant Ascites
      • alfapump system
      • London, United Kingdom
        Hammersmith Hospital
      Aug 6, 2020

      Liver Cirrhoses, Malignant Ascites Trial in Leipzig, Bern (Alfapump)

      Recruiting
      • Liver Cirrhoses
      • Malignant Ascites
      • Alfapump
      • Leipzig, Germany
      • +1 more
      Oct 23, 2020

      Brenner Tumor, Malignant Ascites, Malignant Pleural Effusion Trial in United States (metformin HCl, , Chemotherapy)

      Suspended
      • Brenner Tumor
      • +27 more
      • metformin hydrochloride
      • +2 more
      • Birmingham, Alabama
      • +9 more
      May 16, 2022

      Liver Cirrhosis, Refractory Ascites, Malignant Ascites Trial in Worldwide

      Completed
      • Liver Cirrhosis
      • +2 more
        • Dresden, Germany
        • +12 more
        Oct 23, 2020

        Cancer & Immune Cells in Ascites Fluid of Ovarian Cancer

        Recruiting
        • Ovarian Cancer
          • Albuquerque, New Mexico
            University of New Mexico Cancer Center
          Oct 4, 2022

          Immune Checkpoints in Intraabdominal Ascites Fluid

          Completed
          • Colorectal Cancer
          • Flow-cytometric analysis
          • Istanbul, Turkey
            Ufuk Oguz Idiz
          Dec 4, 2022

          Ascites Trial in Houston (Albumin)

          Recruiting
          • Ascites
          • Houston, Texas
            Baylor St' Lukes Medical center
          May 10, 2023

          Malignant Ascites Trial in Gdynia (device, behavioral, other)

          Unknown status
          • Malignant Ascites
          • Ascites drainage with vascular catheter.
          • +4 more
          • Gdynia, Poland
            Gdynia Oncology Center
          Apr 3, 2019

          Liquid Biopsy With Immunomagnetic Beads Capture Technique for

          Unknown status
          • Malignancy
          • +3 more
          • Immunomagnetic Detection
          • Nanjing, Jiangsu, China
          • +1 more
          Feb 4, 2020